Zymeworks (ZYME) Operating Margin Growth (1y) (2022 - 2026)

Zymeworks (ZYME) Operating Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,552.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,536.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -170.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1,049.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Zymeworks 1.73 Bn 1.36 Bn - -186,225.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -186,225.00
Dec 31, 2025 -168,395.00
Sep 30, 2025 13,371.00
Jun 30, 2025 22,148.00
Mar 31, 2025 28,241.00
Dec 31, 2024 6,678.00
Sep 30, 2024 -1,242.00
Jun 30, 2024 54,997.00
Mar 31, 2024 -30,021.00
Dec 31, 2023 -23,665.00
Sep 30, 2023 171,266.00
Jun 30, 2023 43,670.00
Mar 31, 2023 371,695.00
Dec 31, 2022 60,889.00
Sep 30, 2022 -52,690.00